A hybridoma cell line producing the monoclonal antibody against erythropoietin receptor (EpoR) was established using the soluble ectodomain of mouse erythropoietin receptor (sEpoR) as an antigen. The monoclonal antibody termed 1G3 bound to the denatured sEpoR. Epitope mapping with peptide library revealed that 163 recognized the amino terminal region including the hexapeptide (positions 6 to 11; LeuProAspProLysPhe). The amino acid sequence in this hexapeptide was identical in mice, rats, and humans, and there-
A hybridoma cell line producing the monoclonal antibody against erythropoietin receptor (EpoR) was established using the soluble ectodomain of mouse erythropoietin receptor (sEpoR) as an antigen. The monoclonal antibody termed 1G3 bound to the denatured sEpoR. Epitope mapping with peptide library revealed that 163 recognized the amino terminal region including the hexapeptide (positions 6 to 11; LeuProAspProLysPhe). The amino acid sequence in this hexapeptide was identical in mice, rats, and humans, and there-RYTHROPOIETIN (Epo) regulates erythropoiesis by E supporting the survival of erythroid precursor cells and stimulating their proliferation and differentiation. The action of Epo is mediated by binding to the specific receptor (EpoR) expressed on the cell surface. Molecular cloning of murine'~' and human E~o R~,~ has revealed that the mature EpoR consists of an extracellular amino terminal domain containing 225 to 226 amino acid residues, 22 amino acid transmembrane region, and an intracellular domain containing 236 amino acid residues. A number of growth factor receptors exist in soluble forms (extracellular domain) in the biologic fluids. These include receptors for Epo,' leukemia inhibitory factor,' interleukin-1 (IL-l),' IL-2: IL-4,' IL-6,'' and growth hormone." Although the physiologic functions of the soluble receptors have not yet been established, they are implicated in regulation of the ligand concentration. Soluble receptors have also been shown to be associated with some diseases, and their concentrations can be indicators in diagnosis of diseases." Soluble EpoR (sEpoR) has been found in sera from patients with enhanced erythrop~iesis.~ This has been shown with Westem blotting using polyclonal antibodies against the amino terminal region of EpoR. A more quantitative assay for sEpoR in biologic fluids would be valuable for understanding the function of sEpoR and also the mechanism by which sEpoR expression is enhanced.
Epo has been believed to act exclusively on erythroid precursor cells in vivo, but this notion has been challenged by some reports indicating that Epo is involved in neuronal fun~tions.~.'~-'' Expression of EpoR has also been reported in some other nonerythroid cells, including megakaryocytes," vascular endothelial cells," Leydig cells," embryonal stem cells," and fetal liver stromal cells. 22 Monoclonal antibodies (MoAb) specific for EpoR have been reported, but they all react with human EpoR but not with murine EpoR.'' We have prepared MoAb capable of recognizing both human and murine EpoR. In this report we describe the characteristics of the MoAb including the epitope determined by the use of a random peptide library.24 This MoAb is used for measurement of sEpoR, identification of nonerythroid cells expressing EpoR as well as erythroid cells, and detection of the solubilized transmembrane EpoR.
MATERIALS AND METHODS
Materials were obtained from the indicated sources: Maxisorp microtiter plate (Nunc, Copenhagen, Sweden); peroxidase
Materials.
fore 163 bound to EpoR from all of these sources. Using 163, we evaluated sEpoR by a sandwich enzyme-linked immunoassay, and EpoR in the solubilized membrane preparation was detected by Western blotting. The cells expressing EpoR were identified with immunochemical staining. We confirmed the presence of EpoR in a neuronal cell line and PC12 cells, and EpoR was expressed in primary cuttured hippocampal neurons. 0 1996 by The American Society of Hematology.
coloring kit (Sumiron, Tokyo, Japan); Vectastain avidin-biotinhorseradish peroxidase complex (ABC) kit and N-HydroxysuccinimidyL6-(biotinamide) hexanoate (biotin [long arm] NHS; Vector Laboratories, Burlingame, CA); anti-c-Myc monoclonal antibody that recognizes the carboxyterminal peptide of c-Myc (Oncogene Science, Cambridge, MA); insulin-transfemn-selenium-X (ITS-X; GIBCO, Grand Island, NY); ultrafilter Molcut M (Millipore, Nihon Millipore Ltd, Tokyo, Japan). The soluble ectodomain of mouse EpoR (sEpoR) capable of binding with Epo was prepared as described previo~sly?~ and human sEpoR was a kind gift from Dr S.S. Jones (Genetics Institute Inc, Cambridge, MA).26 The sEpoR was stored at -80°C until use and was diluted with 10 mmol/L phosphate-buffered saline (PBS), pH 7.4 containing 0.1% bovine serum albumin (BSA).
Cells were cultured in the media containing 100 ,ug/mL streptomycin and 100 IU/mL penicillin in a humid 5% or 10% C 0 2 atmosphere. NSlIl-Ag4-I; Sp2/0-Ag14; and TSA8, BaF-B03, BaF-BO3 expressing mouse EpoR and UT-7 were maintained in RPMI 1640 medium containing 10% fetal calf serum (FCS) in a 5% CO, atmosphere. BaF-BO3 and BaF-BO3 expressing EpoR were maintained in the presence of 10% WEHI3B-conditioned medium as a source of IL-3 and UT-7 cells were maintained in the presence of 5 ng/mL granulocyte-macrophage colony-stimulating factor. PC12 was maintained in Dulbecco's modified Eagle's medium (DMEM) containing 5% FCS and 10% horse serum in a 10% C 0 2 atmosphere.
Primary cultures of dissociated hippocampal neurons were prepared from the brains of 19-day Wistar fetal rats. Tissue fragments of the hippocampal areas were dissected from the cerebral tissue Cells and cell culture. (56°C for 1 hour) sEpoR was fixed. The mixture was rotated at 4°C overnight, and the gel was packed in a column. The column was washed with 10 mL of PBS and then the bound IgY was eluted with 3 mL of 0.5 molL NaCl containing 0.2 molL sodium acetate, pH 5. 4, and 3 in this order. The IgY eluted at pH 3 was used.
A Balb/c mouse 8 weeks old was immunized intraperitoneally with 100 pg of the mouse sEpoR in Freund's complete adjuvant, and the immunization was boosted three times with 100 pg of the antigen in Freund's incomplete adjuvant at 2-week intervals. Four mice were immunized and their spleens were removed 3 days after the last boost.
The spleen cells from a mouse were fused with 2 X IO7 NSI/IAg4-I myeloma or Sp210-Ag14 cells using 50% polyethylene glycol.
The hybridomas were resuspended in HAT medium (RPMI 1640 medium containing 10% FCS, 100 pmol/L hypoxanthine, 0.4 pmol/ L aminoputerin, and 16 pmol/L thymidine). The cells were inoculated in three 96-well plates and grown in a S% COz atmosphere. The culture medium was changed every 3 days. Hybridomas were cultured for 2 weeks, and the culture supernatant was screened for production of the anti-sEpoR antibody described below. The hybridomas that were positive in the second screening were cloned twice by the limiting dilution method. The ascitic fluid was generated by injecting I X IO7 hybridoma cells into the pristane-primed mice.
MoAb against mouse sEpoR. after removal of meninges from the brains. The fragments were dissociated by trypsin digestion, and the dissociated cells were washed with DMEM supplemented with 10% FCS. The cells were suspended in the same medium and plated at a density of 2.5 X 10' cells/cmz in poly-L-lysine-coated wells. After 1 day of culture in a 5% COz atmosphere, the medium was changed with the serum-free medium (DMEM containing 1% ITS-X and 15 m o 1 L HEPES) to repress the growth of glial cells. Half of the culture medium was changed every 3 days, and the mature neurons after culture for 7 days were used for immunochemical detection of EpoR. Immunochemical staining of the cells with the MoAb against microtubule-associated protein-2, a specific marker of neurons, indicated that most of the cells were neurons.
sEPO-R (pg)
The parental BaF-BO3 cells grow in the presence of IL-3 and do not express EPOR. BaFEpoR cells expressing EpoR were prepared as described p r e v i o~s l y .~~ To prepare BaFEpoRmyc cells, which express EpoR whose carboxyterminal was tagged with the carboxyterminal decapeptide (EQKLISEEDL) of c-Myc, BaF-BO3 cells were transfected with the plasmid (pEFneoEPORmyc) in which transcription for the EpoRmyc fusion protein was driven by the promoter for EF-la. Both BaF cell lines expressing EpoR or EpoRmyc can grow in the presence of either Epo or IL-3.
Hens were immunized with mouse sEpoR, and the antibody (IgY) was purified from egg yolk as reported p r e v i o u~l y .~~~~~ The immunization was done with 0.5 mg of sEpoR and was boosted two times. To prepare IgY with high affinity to sEpoR, the antibody was fractionated using sEpoR-fixed gel. One milliliter of the IgY solution (10 mg/mL in PBS) was mixed with 2 mL of a gel to which the heat-denatured Chicken polyclonal antibody against mouse sEpoR.
The MoAb was precipitated with 50% ammonium sulfate and purified with a protein G column.
To screen hybridoma cells producing MoAb against EpoR, the EIA was done as previously described."' Briefly, the wells in a Maxisorp microtiter plate were coated with sEpoR by adding 100 pL (per well) of PBS that contained sEpoR at 10 pg/mL and incubating the plate at 4°C overnight. After extensively washing with the washing buffer (PBS containing 0.0S% Tween 20), the unoccupied binding sites were blocked by the normal goat serum and washed three times with the washing buffer. Then, the culture supernatant of hybridoma cells (100 pL per well) was added and the plates were incubated for 2 hours. To the plates washed three times with the washing buffer, horseradish peroxidase-conjugated goat antimouse IgG antibody ( 100 pL/well) dded. The plates were incubated for 2 hours and extensively washed with the washing buffer. The sEpoR-specific antibody was detected with a peroxidase coloring kit. We obtained one hybridoma clone producing MoAb (termed 1G3) that binds with sEpoR.
For competitive EIA, the microtiter wells were coated with sEpoR and the unoccupied binding sites were blocked by the normal goat serum. MoAb 1G3 (10 pg in 100 pL) was added to the wells and the IC3 bound to the fixed sEpoR was measured as described above. Before addition of 1G3, 1G3 was preincubated at 37°C for 30 minutes with a competitor that might inhibit binding of IG3 to sEpoR.
Sandwich EIA using MoAb 1G3 and the anti-sEpoR polyclonal antibody (IgY) was done to measure sEpoR in serum. The wells in a plate were coated with 1G3 by adding 50 pL (per well) of PBS that contained lG3 at I O pg/mL and incubating the plate at 4°C overnight. After extensively washing with the washing buffer, the wells were blocked by the normal goat serum and washed with the washing buffer. Then, the standard sEpoR or the samples (50 pL per well) were added to the wells, and the plate was incubated at 37°C for 1 hour. After washing with the washing buffer, the antisEpoR IgY (50 pL per well) was added, and the plate was incubated at 37°C for 1 hour. The plate was washed with the washing buffer, and then biotinylated goat anti-IgY antibody (50 pL per well) was added. The plate was incubated at 37°C for 1 hour and washed with the washing buffer. To the washed plate, an ABC kit (50 pL/well) was added, and the plate was washed with the washing buffer. Peroxidase activity bound to the wells was determined by the measurement of absorbance at 450 nm using the peroxidase coloring kit.
Enzyme-linked immunoassay ( H A
The epitope of anti-sEpoR MoAb 1G3 was determined using the random peptide phage library kindly provided by Dr G.P. Smith (Division of Biological Sciences, University of Missouri, Columbia, MO).24 BSA dialyzed against PBS was used. A polystyrene dish 35 mm in diameter was coated with 1 mL of 10 pg/mL streptavidin in 0.1 m o m NaHCO, overnight at 4°C and then blocked with 5 mg/mL BSA in 0.1 m o m NaHCO, containing 0.02% NaN3 for 90 minutes at 4°C. The dish was washed six times with 10 mmom Tris-HC1-buffered saline, pH 7.4, containing 0.05% Tween 20 (TBSTTween). To the dish, 400 pL of 25 pg/mL biotinylated 1G3 in TBSiTween containing 1 mg/mL BSA and 0.02% NaN3 was added, and then the dish was incubated for 3 hours at 4°C. To block the remaining biotin binding sites of streptavidin, 4 pL of 10 mmom biotin in TBSiTween was added, and the dish was incubated for 1 hour at 4°C. To the dish washed six times with TBSlTween, 10" virions of phage expressing the random peptides was added, and the dish was incubated for 4 hours at 4°C. To remove the free Epitope mapping.
phage particles, the dish was washed 10 times with TBSiTween and the phage particles bound to lG3 were eluted with 400 pL of 0.1 mom HCl containing 1 mg/mL BSA and 0.1 mg/mL phenol red. The eluted fraction was neutralized with 50 pL of 1 mol/L Tris-C1, pH 9.1, and the buffer was exchanged with 50 mom Tris-C1, pH 7.5, containing 150 mmol/L NaC1. The phages were amplified in liquid culture and subjected to second and third rounds of affinity purification with the same procedure. The purified phages were mixed with biotinylated 1G3 and the phage-lG3 complexes were panned with the streptavidin-coated dish. The phages bound to the dish were eluted as described above. Twenty phages were picked up at random, and the phage DNAs were extracted for sequencing.
In a siliconized tube, 100 pg 1G3 was mixed with 4.4 pL of 1 m o a NaHCOJ and H,O was added to bring the total volume to 24 pL. To the mixture, 20
pL of 20 mg/mL biotin (long arm) NHS was added, and the reaction was allowed to proceed for 2 hours at room temperature. To use up the residual biotin (long arm) NHS, 500 mL of 1 m o m ethanolamine buffer, pH 9.0, was added and the mixture was incubated for 2 hours at room temperature. As a canier, 20 pL of 50 mg/mL BSA was added to the tube and the volume was brought up to 1 mL with TBS. The resulting solution was ultrafiltrated to concentrate the biotinylated 1G3 and to exchange the buffer with PBS. Western blotting of sEpoR and the solubilized transmembrane EpoR. The intact transmembrane EPOR was solubilized from the human and mouse cells and concentrated as described previo~sly.~ The concentrated proteins were separated by electrophoresis with sodium dodecyl sulfate-polyacrylamide gel. Western blotting was done as described p r e v i o~s l y~.~~ using 1G3 and the antimouse IgG antibody. Cells were fixed to the wells by incubation with 0.1 m o m phosphate buffer, pH 7.4, containing 4% paraformaldehyde, 0.35% glutaraldehyde, and 1% picric acid for 30 minutes at 4°C and then with the same buffer without glutaraldehyde at 4°C overnight. After the cells were kept in 15% sucrose solution for 2 days at 4"C, they were washed with 0.1 m o m phosphate buffer, pH 7.4, containing 0.3% Triton X-100 and incubated at 60°C for 1 hour to ensure the denaturation of EpoR. The cells were incubated in 0.1 mol/L phosphate buffer, pH 7.4, containing 0.3% Triton X-100 and 0.3 m m o m sodium metaperiodate for l hour at room temperature and then in 10% normal goat serum for 1 hour. The cells were treated with 1G3, biotinylated goat antimouse IgG antibody, and ABC kit, in this order. EPOR-positive cells were visualized with diaminobenzidine and Hz02.
Biotinylation of anti-sEpoR MoAb IG3.

Immunochemical staining of the cells expressing EpoR.
RESULTS AND DISCUSSION
Characterization and epitope mapping of MoAb lG3.
To obtain hybridoma cells producing anti-EpoR MoAb, the soluble e~t o d o m a i n~~ of mouse EpoR was administered to mice as an antigen. Because EpoR is expressed in the postimplantation mouse embryo,31 we expected difficulty in obtaining hybridoma cells producing MoAb that recognizes the native form of EpoR. Cultured supematants of hybridoma cells, therefore, were screened with the steps to detect antibodies, including those that interact with the denatured sEpoR. In the first screening, the antigen was fixed in microtiter wells. The wells included the denatured form as well as the native form because the fixation has been shown to induce a conformational change of an ar~tigen.~'.~~ The supernatants were examined for binding with the fixed sEpoR using an IgG-detection kit. Thirty-eight cultured supemaFor personal use only. on October 3, 2017. by guest www.bloodjournal.org From tants in 943 wells where the HAT medium-resistant cells grew were positive and were screened again by competitive EIA in which the native mouse sEpoR or the heat-denatured form was added as a competitor for binding of antibodies in the supernatant with the fixed antigen. Binding of the antibody in one supematant was severely blocked by sEpoR. The cells producing the MoAb termed IG3 were cloned by limiting dilution, and the MoAb 1G3 was purified from the ascitic fluid of mice receiving an injection of the cloned hybridoma cells. The subclass of MoAb 1G3 was IgGI.
In the screening step described above, we found that 1G3 bound with both the native and heat-denatured forms of mouse sEpoR. To know which form is favorable for 1G3, a competitive EIA was done with different amounts of the native sEpoR or the heat-denatured form. As Fig 1 shows, the denatured s E p R competed with the fixed sEpoR in binding to MoAb 1G3 with far greater efficiency than the native s E p R did. It remains unknown whether 1G3 interacts with only the denatured sEpoR or also with the native form with a low affinity, because the possibility has not been excluded that the native sEpoR preparation might contain a small amount of the denatured form. Treatment of sEpoR for 30 minutes at 56OC yielded the denatured sEpoR with the full activity as a competitor. The denatured human sEpoR also competed with the fixed mouse s E p R in binding to 1G3 (data not shown). Competition with the native human sEpoR was much less efficient than the denatured form.
An epitope library is very powerful to survey the peptide that tightly binds with an antibody, leading to the identifica- tion of the epitope structure recognized by the MoAb of interest.*' In this method, a vast variety of peptides are expressed on the surface of filamentous bacteriophages by fusion to a phage coat protein. The phages displaying peptides with high affinity to MoAb can be selected by panning the library on the MoAb fixed to a solid support. We used the epitope library in which hexapeptide epitopes were displayed on the coat protein." With affinity purification of phages using the fixed MoAb 1G3 (see Materials and Methods), we obtained 20 phage clones that tightly bound to the fixed MoAb. The phage clone that we first determined the nucleotide sequence contained the hexapeptide amino acid sequence highly homologous to the sequence of the amino terminal region in sEpoR (Fig 2) . Although we have not examined other clones, this finding indicates that 1G3 binds with the amino terminal region of EpoR. To confirm this, a competitive EIA was done using the synthetic pentadecapeptide of the amino terminal in mouse EpoR (see Fig 2) ; mouse s E p R was fixed in wells and binding of 1G3 to the fixed s E p R was examined in the presence of the pentadecapeptide or C3a peptide (pentadecapeptide, see legend of Fig 3) with an unrelated sequence. As Fig 3 shows , the pentadecapeptide of mouse sEpoR inhibited the binding of 1G3, whereas C3a peptide did not.
The amino terminal region of EpoR either forms a conformation that disrupts the structure recognized by 1G3 or may be buried in the inner part of the molecule, to which the antibody is difficult to access. The sequence of the amino terminal pentadecapeptide in EpoR is identical in humans,'" mice,' and rats' except for positions 2, 3, and 5 (see Fig 2) . Because the MoAb 1G3 recognizes the sequence identical in humans and mice, this antibody reacts with EpoR of these sources. D'Andrea et alZ3 immunized mice or hamsters with For personal use only. on October 3, 2017. by guest www.bloodjournal.org From human sEpoR, and their MoAbs bound with human EpoR but not with murine EpoR. The MoAb 1G3 was fixed in microtiter wells and then the native sEpoR or the heat-denatured sEpoR was bound to the fixed antibody. Bound sEpoR was measured using chicken polyclonal antibody against mouse sEpoR (see Materials and Methods). Figure 4 shows the results. As expected, the heatdenatured sEpoR was measured with a very high sensitivity compared with the native form. When IgGl MoAb against tran~glutaminase~~ was fixed in the wells instead of 1G3, neither the denatured sEpoR nor the native form was bound to the fixed antibody (data not shown).
We examined the conditions by which sEpoR in serum could be measured with sandwich EIA (Fig 4) . Known amounts of sEpoR were added to rat serum, and the mixtures were incubated at 56°C for 30 minutes for denaturation of sEpoR. When sEpoR was added in 10% serum, sEpoR could be measured with a sensitivity close to that of denatured sEpoR alone. When sEpoR was added to nondiluted serum and the mixture was incubated at 56°C for 30 minutes; however, the dose-response curve shifted to the right with a reduced sensitivity. Serum may contain a component(s) that prevents sEpoR from heat-denaturation. However, a similar curve was obtained when the denatured sEpoR was added to the nondiluted serum, indicating that an as yet unidentified serum component(s) disturbed the assay. Binding of sEpoR with Epo may render sEpoR heat-resistant, and therefore we examined the effect of Epo on measurement of sEpoR. Addition of Epo in IO-fold excess in the sEpoR preparation, 10% serudsEpoR mixture, and nondiluted serudsEpoR mixture had little effect. Thus, the method described here assays sEpoR in serum irrespective of Epo concentration in serum. 
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Identification qf the solubilized EpoR and detection of the cells expressing EpoR. As described above, our MoAb 1G3 interacts with the denatured form, indicating that this antibody is useful for identification of EpoR by Western blotting and immunocytochemical detection of EpoR-bearing cells. Figure 5 shows Western blotting of human and mouse sEpoRs, confirming that 1G3 binds with EpoRs from both sources. Their size of 33 kD is consistent with that reported for mouse and human sE~oR.~'.~' Next, we detected the fulllength EpoR solubilized from various cells. The solubilized membrane samples were prepared, and EpoR was detected with Western blotting using IG3 (Fig 6) . BaF cells are IL-3-dependent lymphoid cells, and the cells stably transfected with the EpoR cDNA grow in the presence of Epo or IL- 
-33
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From (C and D) . The rat cell line FC12, which has been established from an adrenal medullary pheochromocytoma, has neuronal properties" and expresses EpoR.' PC 12 cells were stained with 1G3, but its reactivity disappeared on preincubation with the denatured sEpoR (E and F). Likewise, cultured hippocampal neurons were reactive with the untreated 1G3 but not with the sEpoR-treated 1G3 (G and H). Thus, EpoR is expressed in neurons, and Epo is produced by astrocytes in an oxygen-dependent fashion.14 Epo protects cultured hippocampal neurons from glutamate-induced cell death (Morishita et al, submitted) . The blood-brain barrier insulates the central nervous system from circulation, preventing the access of blood Epo to the neurons. Taken together, it is very likely that Epo functions in a paracrine fashion as a neurotrophic factor in the brain. Homozygous mice carrying null mutations in the Epo or EpoR genes died around embryonic day 13: ' which has made it difficult to analyze the function of Epo in the brain. The combined use of staining with EpoR-specific MoAb, binding with labeled Epo, and detection of EpoR mRNA with in situ hybridization will define neurons expressing EpoR more precisely and certainly contribute to reveal the physiological function of the Epo signal in the brain. In addition to neurons, MoAb 1G3 may be useful for identification of nonerythroid cells expressing E P O R .~~-~~
